June. 30, 2014 |
|
Dec. 17, 2018 |
|
jRCT2080222546 |
Phase 2 study to evaluate efficacy and safety of DS-8500a in patients with Type 2 Diabetes Mellitus |
|
Phase 2 study of DS-8500a |
version: date: |
DAIICHISANKYO Co.,Ltd. |
||
http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html |
||
90 | ||
Interventional |
||
Randomized, double-blind, parallel-group study |
||
2 |
||
Main Inclusion Criteria; |
||
Main Exclusion Criteria; |
||
20age old over | ||
69age old under | ||
Both |
||
Type 2 Diabetes Mellitus |
||
investigational material(s) |
||
24hr-weighted mean glucose |
||
Safety, Pharmacokinetics |
DAIICHISANKYO Co.,Ltd. | |
JapicCTI-142597 | |